2 February 2023 - In an environment where gastric cancer treatments are currently lacking, the approval of Enhertu (ingredient: trastuzumab ...
2 February 2023 - New results from an early-initiated study show advantages in overall survival. ...
1 February 2023 - Nintedanib esylate is recommended as an option for the treatment of adults with idiopathic pulmonary fibrosis ...
1 February 2023 - Somatrogon is recommended as an option for the treatment of children 3 years of age and over ...
1 February 2023 - Trastuzumab deruxtecan is recommended with managed access as an option for the treatment of adults with HER2 ...
1 February 2023 - Upadacitinib monohydrate is recommended as an option for the treatment of adults with active non-radiographic axial ...
31 January 2023 - Jazz Pharmaceuticals today announced that Epidyolex (cannabidiol 100 mg/mL oral solution), developed by GW Pharmaceuticals, has been ...
27 January 2023 - Four new medicines recommended for approval. ...
27 January 2023 - Recommendation based on a Phase 3 trial in children 6 months to 5 years old showing Dupixent ...
27 January 2023 - Recommendations made by the PBAC in December 2022 relating to the listing of drugs on the PBS ...
27 January 2023 - The Department of Health and Social Care has asked NICE to produce guidance on using risankizumab in ...
27 January 2023 - The MSAC Secretariat has published a list of applications scheduled to be considered by the PICO Advisory ...
26 January 2023 - As the Government moves toward expanding insurance coverage for atopic dermatitis from adult to children and ...
26 January 2023 - The new deadline is 28 February 2023. ...
26 January 2023 - Hundreds of people with an aggressive form of lymphoma are set to benefit from the first ...